Making sense of colorectal cancer screening choices

Colorectal cancer is the third most common cause of cancer death among men and women in the U.S. But there is shockingly large regional variation in mortality, in part because of sharp differences...

Clearing the quandary of cancer early detection

For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading. But efforts to detect cancers early have led to a...

New funding for a dire need: Pancreas cancer early detection

With a $250,000 award from the Pancreatic Cancer Action Network, researchers will seek to validate biomarkers able to detect pancreas cancer months or years before patients experience overt symptoms...

Mole Mapper brings open data for cancer research

A new report in Nature Scientific Data explains how researchers can access and use the growing trove of data coming from users of Mole Mapper, a mobile app for tracking suspicious...

First in philanthropy: Phil and Penny Knight

Phil Knight and Brian Druker, M.D., on "Good Morning America" in 2015. Nike co-founder Phil Knight and his wife Penny ranked no. 1 in The Chronicle of Philanthropy list of Americans who donated...

What to make of smart machines that may soon outperform doctors

Artificial neural networks are getting really good at identifying skin cancer The first artificial intelligence to solve scientific problems debuted in 1967, when it proved capable of deducing...

Knight Cancer signal achievements of 2016

The staff and faculty of the OHSU Knight Cancer Institute accomplished much together during the past year. Here's a sampling of achievements that reflect the mission of delivering compassionate care...

The ‘Cancer translated’ blog top ten posts of 2016

The OHSU Knight Cancer Institute’s "Cancer translated" blog explores new findings, ideas and debates in cancer medicine, from basic biology, to clinical trials, to prevention, survivorship and...

Predicting colon polyp risk from microRNA

Differences in microRNA in colon polyps may help identify high risk cases that require more frequent follow-up screening, according to a study with four OHSU co-authors that is featured on the cover...